Literature DB >> 20175879

Reduced skin homing by functional Treg in vitiligo.

Jared Klarquist1, Cecele J Denman, Claudia Hernandez, Derek A Wainwright, Derek J Wainwright, Faith M Strickland, Andreas Overbeck, Shikar Mehrotra, Michael I Nishimura, I Caroline Le Poole.   

Abstract

In human vitiligo, cutaneous depigmentation involves cytotoxic activity of autoreactive T cells. It was hypothesized that depigmentation can progress in the absence of regulatory T cells (Treg). The percentage of Treg among skin infiltrating T cells was evaluated by immunoenzymatic double staining for CD3 and FoxP3, revealing drastically reduced numbers of Treg in non-lesional, perilesional and lesional vitiligo skin. Assessment of the circulating Treg pool by FACS analysis of CD4, CD25, CD127 and FoxP3 expression, and mixed lymphocyte reactions in presence and absence of sorted Treg revealed no systemic drop in the abundance or activity of Treg in vitiligo patients. Expression of skin homing receptors CCR4, CCR5, CCR8 and CLA was comparable among circulating vitiligo and control Treg. Treg from either source were equally capable of migrating towards CCR4 ligand and skin homing chemokine CCL22, yet significantly reduced expression of CCL22 in vitiligo skin observed by immunohistochemistry may explain failure of circulating, functional Treg to home to the skin in vitiligo. The paucity of Treg in vitiligo skin is likely crucial for perpetual anti-melanocyte reactivity in progressive disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20175879      PMCID: PMC3778930          DOI: 10.1111/j.1755-148X.2010.00688.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  40 in total

Review 1.  T-cell avidity and tuning: the flexible connection between tolerance and autoimmunity.

Authors:  Jasper G van den Boorn; I Caroline Le Poole; Rosalie M Luiten
Journal:  Int Rev Immunol       Date:  2006 May-Aug       Impact factor: 5.311

2.  Familial coexisting and colocalized psoriasis and vitiligo responding to alefacept.

Authors:  Nawaf Al-Mutairi; Azari Al-Doukhi
Journal:  J Cutan Med Surg       Date:  2009 May-Jun       Impact factor: 2.092

3.  Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity.

Authors:  Smita Nair; David Boczkowski; Martin Fassnacht; David Pisetsky; Eli Gilboa
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

Review 4.  Induction and maintenance of self tolerance: the role of CD4+CD25+ regulatory T cells.

Authors:  Kamalesh K Bala; Kamal D Moudgil
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2006-10-06       Impact factor: 4.291

Review 5.  Therapeutic implications of autoimmune vitiligo T cells.

Authors:  Kepa Oyarbide-Valencia; Jasper G van den Boorn; Cecele J Denman; Mingli Li; Jeremy M Carlson; Claudia Hernandez; Michael I Nishimura; Pranab K Das; Rosalie M Luiten; I Caroline Le Poole
Journal:  Autoimmun Rev       Date:  2006-05-06       Impact factor: 9.754

6.  Depletion of CD4+CD25+ human regulatory T cells in vivo: kinetics of Treg depletion and alterations in immune functions in vivo and in vitro.

Authors:  Karsten Mahnke; Kurt Schönfeld; Sabine Fondel; Sabine Ring; Svetlana Karakhanova; Katharina Wiedemeyer; Tanja Bedke; Theron Scott Johnson; Volker Storn; Sonja Schallenberg; Alexander Herrmann Enk
Journal:  Int J Cancer       Date:  2007-06-15       Impact factor: 7.396

7.  CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells.

Authors:  M J Visseren; A van Elsas; E I van der Voort; M E Ressing; W M Kast; P I Schrier; C J Melief
Journal:  J Immunol       Date:  1995-04-15       Impact factor: 5.422

8.  Skin-versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells.

Authors:  Andrea Iellem; Lucia Colantonio; Daniele D'Ambrosio
Journal:  Eur J Immunol       Date:  2003-06       Impact factor: 5.532

9.  Interferon-gamma is an autocrine mediator for dendritic cell maturation.

Authors:  Jianping Pan; Minghui Zhang; Jianli Wang; Qingqing Wang; Dajing Xia; Wenji Sun; Lihuang Zhang; Hai Yu; Yongjun Liu; Xuetao Cao
Journal:  Immunol Lett       Date:  2004-06-15       Impact factor: 3.685

10.  HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo.

Authors:  Cecele J Denman; James McCracken; Vidhya Hariharan; Jared Klarquist; Kepa Oyarbide-Valencia; José A Guevara-Patiño; I Caroline Le Poole
Journal:  J Invest Dermatol       Date:  2008-03-13       Impact factor: 8.551

View more
  48 in total

1.  Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells.

Authors:  Li Zhou; Kai Li; Yu-Ling Shi; Iltefat Hamzavi; Tian-Wen Gao; Marsha Henderson; Richard H Huggins; Oma Agbai; Bassel Mahmoud; Xiaofan Mi; Henry W Lim; Qing-Sheng Mi
Journal:  Pigment Cell Melanoma Res       Date:  2012-07-12       Impact factor: 4.693

2.  Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma.

Authors:  Jared Klarquist; Kristen Tobin; Peyman Farhangi Oskuei; Steven W Henning; Manuel F Fernandez; Emilia R Dellacecca; Flor C Navarro; Jonathan M Eby; Shilpak Chatterjee; Shikhar Mehrotra; Joseph I Clark; I Caroline Le Poole
Journal:  Cancer Res       Date:  2016-09-12       Impact factor: 12.701

Review 3.  Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.

Authors:  Katia Boniface; Julien Seneschal; Mauro Picardo; Alain Taïeb
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

4.  Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo.

Authors:  Kirsten C Webb; Jonathan M Eby; Vidhya Hariharan; Claudia Hernandez; Rosalie M Luiten; I Caroline Le Poole
Journal:  Exp Dermatol       Date:  2014-07-10       Impact factor: 3.960

Review 5.  T-cell positioning by chemokines in autoimmune skin diseases.

Authors:  Jillian M Richmond; James P Strassner; Kingsley I Essien; John E Harris
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

6.  Participation of T cell immunoglobulin and mucin domain-3 (TIM-3) and its ligand (galectin-9) in the pathogenesis of active generalized vitiligo.

Authors:  Manoj Kumar Tembhre; Anita Singh Parihar; Alpana Sharma; Somesh Gupta; Parthaprasad Chattopadhyay; Vinod Kumar Sharma
Journal:  Immunol Res       Date:  2015-05       Impact factor: 2.829

Review 7.  Understanding mechanisms of autoimmunity through translational research in vitiligo.

Authors:  James P Strassner; John E Harris
Journal:  Curr Opin Immunol       Date:  2016-10-17       Impact factor: 7.486

8.  Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation.

Authors:  Jonathan M Eby; Hee-Kap Kang; Jared Klarquist; Shilpak Chatterjee; Jeffrey A Mosenson; Michael I Nishimura; Elizabeth Garrett-Mayer; B Jack Longley; Victor H Engelhard; Shikhar Mehrotra; I Caroline Le Poole
Journal:  Pigment Cell Melanoma Res       Date:  2014-07-21       Impact factor: 4.693

Review 9.  Innate immune mechanisms in vitiligo: danger from within.

Authors:  Jillian M Richmond; Michael L Frisoli; John E Harris
Journal:  Curr Opin Immunol       Date:  2013-11-12       Impact factor: 7.486

10.  Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+ T cells.

Authors:  Arnaud Pommier; Alexandra Audemard; Aurélie Durand; Renée Lengagne; Arnaud Delpoux; Bruno Martin; Laetitia Douguet; Armelle Le Campion; Masashi Kato; Marie-Françoise Avril; Cédric Auffray; Bruno Lucas; Armelle Prévost-Blondel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.